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The recent increase in the number of bacteria that are resistant to drugs, such as methicillin-
resistant S. aureus (MRSA) and vancomycin-resistant Enterococci (VRE), represents a 
significant threat to public health. According to a report by the Centers for Disease Control 
and Prevention [1], for example, 2 million people are infected and 23,000 die each year in 
the United States from bacteria that are resistant to antibiotics; many more deaths occur as 
the result of complications associated with other conditions caused by an antibiotic-resistant 
infection. This increase in drug-resistant bacteria combined with a decline in the 
development of antibiotics, means that drug resistance is an impelling global concern [2]. 
One innovative way to try to address these clinical problems and develop effective therapies 
is to use mechanical signals, rather than chemical or electrical signals, to explore novel 
antibiotic therapies. Nanomechanical sensors based on microcantilevers provide a 
technology platform for label-free and sensitive detection of biomolecular interactions [3] on 
a solid surface. However, the development of a new drug requires a detailed understanding 
of its therapeutic effects in a complex environment, such as in a patient’s blood. Writing in 
Nature Nanotechnology, Joseph Ndieyira, Rachel McKendry and colleagues now show that 
arrays of nanomechanical cantilevers can characterise the mechanical response of the 
bacterial cell wall to antibiotics while taking into account binding to other molecules in 
solutions that reduce their potency [4]. 
 
Nanomechanical sensors work by measuring the bending of a cantilever that is generated by 
molecular binding/adsorption taking place on the surface of the cantilever (Figure 1). The 
cantilever bending is a result of surface stress due to factors such as electrostatic and van 
der Waals forces, as well as conformational changes of molecules and molecular layers 
upon a binding event. The main advantage of the microcantilever technique is the possibility 
to measure forces at the nanoscale, and the versatility of cantilever sensors in life science 
applications has been previously demonstrated through the detection of RNA [5], proteins [6] 
and microorganisms [7]. Spurious effects, such as nonspecific interactions and thermal drift, 
are cancelled out by calculating the differential response of a probe and a reference 
cantilever. 
 
The researchers – who are based at University College London, Jomo Kenyatta University of 
Agriculture and Technology, the University of Queensland and the University of Cambridge – 
investigate the interactions of drug molecules that are in solution with strongly and weakly 
interfering ligands such as the proteins in human serum [4]. Some of these components of 
blood can influence the activity of drugs by binding antibiotics and thereby lowering the 
concentration of the active ingredient. Therefore, the interactions between the drug and 
competing ligands affect the dosage needed for effective treatment, and an in-depth 
understanding of these processes is essential for evaluating the effectiveness of new 
antibiotics, as well as for therapeutic drug monitoring. Furthermore, the researchers find that 
the additional presence of analogous bacterial targets in solution enhances the surface 
binding activity of antibiotics such as vancomycin. This could boost the efficiency of drugs in 
killing bacteria. The method could therefore also be used to evaluate new drugs and 
investigate resistance to antibiotics. 
 
Ndieyira and colleagues use nanomechanical cantilever arrays to explore the mechanisms 
of antibiotic interactions with the bacterial cell wall and the blood/serum constituents at the 
same time. The binding of an antibiotic in solution to bacterial cell wall components causes 
surface stress changes, which illustrates the importance of nanomechanics in antibiotic 
action on bacterial cells [8]. Surface receptors on the cantilevers also probe the impact of 
blood serum on the activity of antimicrobials, allowing the correct dosage for a patient to be 
determined. For each new antibiotic drug that is developed, the influence of serum albumin 
and other proteins must be investigated to evaluate its effect. The nanomechanical 
technique allows antibiotic activity to be analysed quickly and could therefore help refine 
dosage prescriptions.  
 
This nanomechanical technology has a number of advantages over other methods such as 
radioactive or fluorescence labelling in immuno assays, quartz crystal microbalance (QCM) 
[9] or surface plasmon resonance (SPR) [10], including label-free detection of ligands in 
solution, and screening of multiple receptor-ligand interactions in parallel and under identical 
conditions. Ndieyira and colleagues show that methods like SPR are two orders of 
magnitude less sensitive compared to the cantilever approach in the detection of antibiotics 
in solution. Importantly, the researchers demonstrate that distinct changes of surface 
mechanics are drug-specific, and that competing ligands in solution play a fundamental role 
in modulating these mechanical properties. Moreover, they developed a conceptual 
framework that allows quantitative judgments to be made in understanding the mode of 
action of antibiotics in a complex environment.  
 
The direct nanomechanical quantification of dosage effectiveness in clinical studies is a 
prerequisite for personalized healthcare. Additionally, it provides insight into a cure designed 
to optimize treatment outcomes, particularly in a combinational therapy, acting as a platform 
for the early detection of infectious diseases and therapeutic monitoring applications against 
multidrug resistant pathogens. The work of Ndieyira and colleagues represents a new 
approach towards determining the role of chemistry and mechanics in membrane-bound 
receptor and protein assays. 
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Fig. 1 Working principle of nanomechanical microcantilevers. The gold coated surface of 
some of the cantilevers is functionalized with receptor model molecules of Lysine-D-Alanine-
D-Alanine (first and third cantilevers from the left) [4], whilst the other cantilever are 
functionalized with the reference molecule triethylene glycol (second from left), which does 
not allow binding of the ligand. Antibiotic molecules are depicted in blue, floating freely in 
solution and bound to the receptor molecules. The dark red line on the surface of the first 
cantilever shows the force distribution on the cantilever surface, which causes the cantilever 
to bend. Bending is analyzed using a laser beam (shown in bright red, deflecting from the 
middle cantilever), and a position sensitive detector (not shown). Cantilevers are measured 
sequentially. 
 
The picture is taken from: http://www.bio-nano-
consulting.com/NewsAndEvents/Archive%202009/Rachel%20wins%202.aspx 
Please adapt the image or produce a new one similar to this. Add more free ligands 
(in blue) in solution. 
 
